XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jan. 01, 2022   7,362,703    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 $ 215,784 $ (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 11,426   11,426  
Foreign currency translation adjustment (1,172)     (1,172)
Exercise of stock options (in shares)   14,552    
Exercise of stock options 341 $ 341    
Share-based compensation expense 1,037 $ 1,037    
Restricted shares vesting (in shares)   29,558    
Redemption of vested employee restricted shares for tax withholding (in shares)   (10,163)    
Redemption of vested employee restricted shares for tax withholding (897) $ (897)    
Shares repurchased (in shares)   (56,665)    
Shares repurchased (4,956) $ (481) (4,475)  
Accrued dividends on unvested shares (11)   (11)  
Cash dividends paid (per share) (2,377)   (2,377)  
Ending balance (in shares) at Apr. 02, 2022   7,339,985    
Ending balance at Apr. 02, 2022 $ 209,225 $ 0 220,347 (11,122)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.31      
Beginning balance (in shares) at Jan. 01, 2022   7,362,703    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 215,784 (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 34,946      
Foreign currency translation adjustment (8,838)      
Ending balance (in shares) at Oct. 01, 2022   7,108,853    
Ending balance at Oct. 01, 2022 200,675 $ 1,029 218,434 (18,788)
Beginning balance (in shares) at Apr. 02, 2022   7,339,985    
Beginning balance at Apr. 02, 2022 209,225 $ 0 220,347 (11,122)
Increase (Decrease) in Shareholders' Equity        
Net income 11,643   11,643  
Foreign currency translation adjustment (3,860)     (3,860)
Share-based compensation expense 1,041 $ 1,041    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (in shares)   (921)    
Redemption of vested employee restricted shares for tax withholding (78) $ (78)    
Shares repurchased (in shares)   (211,345)    
Shares repurchased (17,674) $ (963) (16,711)  
Accrued dividends on unvested shares (52)   (52)  
Cash dividends paid (per share) (2,259)   (2,259)  
Ending balance (in shares) at Jul. 02, 2022   7,131,349    
Ending balance at Jul. 02, 2022 $ 197,986 $ 0 212,968 (14,982)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.31      
Net income $ 11,877   11,877  
Foreign currency translation adjustment (3,806)     (3,806)
Exercise of stock options (in shares)   19,476    
Exercise of stock options 419 $ 419    
Share-based compensation expense 1,489 $ 1,489    
Restricted shares vesting (in shares)   9,843    
Redemption of vested employee restricted shares for tax withholding (in shares)   (291)    
Redemption of vested employee restricted shares for tax withholding (27) $ (27)    
Shares repurchased (in shares)   (51,524)    
Shares repurchased (5,000) $ (852) (4,148)  
Accrued dividends on unvested shares (39)   (39)  
Cash dividends paid (per share) (2,224)   (2,224)  
Ending balance (in shares) at Oct. 01, 2022   7,108,853    
Ending balance at Oct. 01, 2022 $ 200,675 $ 1,029 218,434 (18,788)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.31      
Beginning balance (in shares) at Dec. 31, 2022 7,149,884 7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 8,918   8,918  
Foreign currency translation adjustment 1,052     1,052
Exercise of stock options (in shares)   0    
Exercise of stock options 0 $ 0    
Share-based compensation expense 940 $ 940    
Restricted shares vesting (in shares)   45,544    
Redemption of vested employee restricted shares for tax withholding (in shares)   (16,614)    
Redemption of vested employee restricted shares for tax withholding (1,873) $ (1,873)    
Shares repurchased (in shares)   (180,881)    
Shares repurchased (20,577) $ (810) (19,767)  
Accrued excise tax on shares repurchased (173)   (173)  
Accrued dividends on unvested shares 45   45  
Cash dividends paid (per share) (2,702)   (2,702)  
Ending balance (in shares) at Apr. 01, 2023   6,997,933    
Ending balance at Apr. 01, 2023 $ 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36      
Beginning balance (in shares) at Dec. 31, 2022 7,149,884 7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 27,022      
Foreign currency translation adjustment $ 371      
Ending balance (in shares) at Sep. 30, 2023 6,978,941 6,978,941    
Ending balance at Sep. 30, 2023 $ 207,958 $ 1,363 221,205 (14,610)
Beginning balance (in shares) at Apr. 01, 2023   6,997,933    
Beginning balance at Apr. 01, 2023 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Net income 9,508   9,508  
Foreign currency translation adjustment 1,074     1,074
Exercise of stock options (in shares)   0    
Exercise of stock options 0 $ 0    
Share-based compensation expense 1,158 $ 1,158    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (in shares)   (1,237)    
Redemption of vested employee restricted shares for tax withholding (136) $ (136)    
Shares repurchased (in shares)   (31,090)    
Shares repurchased (3,000) $ (554) (2,446)  
Accrued excise tax on shares repurchased (27)   (27)  
Accrued dividends on unvested shares (47)   (47)  
Cash dividends paid (per share) (2,528)   (2,528)  
Ending balance (in shares) at Jul. 01, 2023   6,969,236    
Ending balance at Jul. 01, 2023 $ 202,786 $ 468 215,173 (12,855)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36      
Net income $ 8,596   8,596  
Foreign currency translation adjustment (1,755)     (1,755)
Exercise of stock options (in shares)   0    
Exercise of stock options 0 $ 0    
Share-based compensation expense 926 $ 926    
Restricted shares vesting (in shares)   10,004    
Redemption of vested employee restricted shares for tax withholding (in shares)   299    
Redemption of vested employee restricted shares for tax withholding (31) $ (31)    
Shares repurchased (in shares)   0    
Shares repurchased 0 $ 0 0  
Accrued excise tax on shares repurchased 10   10  
Accrued dividends on unvested shares (31)   (31)  
Cash dividends paid (per share) $ (2,543)   (2,543)  
Ending balance (in shares) at Sep. 30, 2023 6,978,941 6,978,941    
Ending balance at Sep. 30, 2023 $ 207,958 $ 1,363 $ 221,205 $ (14,610)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36